TAYLORMED

Electrospray-Mediated Delivery of Biological Molecules into Mammalian Cells

 Coordinatore NATIONAL UNIVERSITY OF IRELAND MAYNOOTH 

 Organization address address: CO KILDARE
city: MAYNOOTH

contact info
Titolo: Dr.
Nome: Shirley
Cognome: O'dea
Email: send email
Telefono: +353 1 708 6117
Fax: +353 1 7086337

 Nazionalità Coordinatore Ireland [IE]
 Totale costo 962˙006 €
 EC contributo 962˙006 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2009-IAPP
 Funding Scheme MC-IAPP
 Anno di inizio 2010
 Periodo (anno-mese-giorno) 2010-08-01   -   2015-02-28

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    NATIONAL UNIVERSITY OF IRELAND MAYNOOTH

 Organization address address: CO KILDARE
city: MAYNOOTH

contact info
Titolo: Dr.
Nome: Shirley
Cognome: O'dea
Email: send email
Telefono: +353 1 708 6117
Fax: +353 1 7086337

IE (MAYNOOTH) coordinator 341˙521.00
2    THE DOLOMITE CENTRE LIMITED

 Organization address address: JARMAN WAY 27
city: ROYSTON
postcode: SG8 5HW

contact info
Titolo: Mr.
Nome: Mark
Cognome: Gilligan
Email: send email
Telefono: +44 1763 242555
Fax: +44 1763 242992

UK (ROYSTON) participant 490˙555.00
3    THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN

 Organization address address: College Green -
city: DUBLIN
postcode: 2

contact info
Titolo: Ms.
Nome: Deirdre
Cognome: Savage
Email: send email
Telefono: 35318961942
Fax: 35317071633

IE (DUBLIN) participant 129˙930.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

drug    engineering    electrospray    biological    molecules    cells    problem    mass    protein    generation    action    successfully    spectrometry    fluid   

 Obiettivo del progetto (Objective)

'This partnership has been created to address the critically poor efficacy of existing treatment strategies to treat lung disease, a major health problem in the EU. The project will research and develop a novel process involving electrospray to deliver biomolecule-based drugs into cells. The action requires intersectorial collaboration between partners with complementary expertise in biological drug delivery, mechanical and manufacturing engineering and microfluidics technologies. The problem will be tackled by researching the parameters that influence electrospray generation and its ability to successfully deliver active biomolecules into cells. The term ‘electrospray’ refers to the process where electrical charges are provided to a fluid in order to generate a very fine spray of the fluid. Applications of electrospray technology include mass spectrometry, chemical deposition and colloid thrusters. Recently, the process has been applied to areas of biology such as protein mass spectrometry, depositing biological material during tissue engineering and the production of protein microarrays. However, the fundamental parameters underlying electrospray formation are poorly understood, limiting full exploitation of the potential of this phenomenon. We have developed a novel electrospray system which we have successfully used to demonstrate a novel application of delivering biological molecules into cells such that they remain functional within the cell. This technology holds substantial potential as a novel drug delivery method. In this interdisciplinary action, we aim to increase understanding of the physical processes involved in electrospray generation, to develop the technology and to determine its potential to deliver of a wide range of biological molecules into cells. The project will significantly advance the area of electrospray-mediated drug delivery with major relevance for pharmaceutical/drug delivery/medical device companies, patients and clinicians in the EU.'

Altri progetti dello stesso programma (FP7-PEOPLE)

LIGHT2NANOGENE (2014)

Cellular bioengineering by plasmonic enhanced laser nanosurgery

Read More  

CANNABIDIM (2012)

Molecular modelling of the cannabinoid CB1 receptor homodimer and its interaction with ligands: the role of membrane cholesterol and the CRIP1a protein

Read More  

UEPHA-MS (2008)

United Europeans for the Development of Pharmacogenomics in Multiple Sclerosis

Read More